Israel Englander’s Immunovant IMVT Stock Holding History

Israel Englander’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45,000	Closed	-$769K	–	6088
2025 Q1	$769K	Buy	+45,000	New	+$941K	﹤0.01%	4544
2024 Q2	–	Sell	-15,300	Closed	-$494K	–	6200
2024 Q1	$494K	Buy	15,300 +400	+3%	+$14.6K	﹤0.01%	4820
2023 Q4	$628K	Sell	14,900 -154,400	-91%	-$5.68M	﹤0.01%	4508
2023 Q3	$6.5M	Buy	169,300 +53,800	+47%	+$1.22M	﹤0.01%	2451
2023 Q2	$2.19M	Buy	+115,500	New	+$2.15M	﹤0.01%	3401
2021 Q3	–	Sell	-100,000	Closed	-$1.06M	–	7001
2021 Q2	$1.06M	Buy	+100,000	New	+$1.4M	﹤0.01%	4610

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Israel Englander's IMVT Position: Q2 2026 in Review

Israel Englander opened a new position in Immunovant (IMVT) in Q2 2026: 328,678 shares worth $12.7M. The stake represents ﹤0.01% of the portfolio and ranks #2053 among its holdings. This is a return to the name: Israel Englander previously reported a position in IMVT as recently as Q4 2025.

Israel Englander first reported a position in IMVT in Q1 2020 and has held it in 25 quarters since. The position peaked at $28.3M in Q4 2023. 224 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

Israel Englander held 328,678 shares of Immunovant worth $12.7M as of Q2 2026.
Immunovant was a new Israel Englander position in Q2 2026.
Immunovant made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2053 holding.
Israel Englander first reported a position in Immunovant in Q1 2020 and has held it in 25 quarters since.
Israel Englander's Immunovant position peaked at $28.3M in Q4 2023.
224 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.